Lexagene Holdings (Lexagene Holdings) Return-on-Tangible-Equity : -357.21% (As of Nov. 2022)

Lexagene Holdings Return-on-Tangible-Equity Chart

Lexagene Holdings Annual Data
	Trend	Mar13	Mar14	Mar15	Feb16	Feb17	Feb18	Feb19	Feb20	Feb21	Feb22
Return-on-Tangible-Equity		Get a 7-Day Free Trial					-189.00	-354.46	-294.54	-135.41	-123.82

Lexagene Holdings Quarterly Data
	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22
Return-on-Tangible-Equity	Get a 7-Day Free Trial															-218.26	-184.04	-157.82	-241.23	-357.21

Competitive Comparison of Lexagene Holdings's Return-on-Tangible-Equity

For the Medical Devices subindustry, Lexagene Holdings's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lexagene Holdings's Return-on-Tangible-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lexagene Holdings's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Lexagene Holdings's Return-on-Tangible-Equity falls into.

Lexagene Holdings Return-on-Tangible-Equity Calculation

Lexagene Holdings's annualized Return-on-Tangible-Equity for the fiscal year that ended in Feb. 2022 is calculated as

Lexagene Holdings's annualized Return-on-Tangible-Equity for the quarter that ended in Nov. 2022 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Nov. 2022) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.

Lexagene Holdings  (OTCPK:LXXGQ) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.

Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.

Lexagene Holdings Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Lexagene Holdings's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Lexagene Holdings (Lexagene Holdings) Business Description